Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 430518, 9 pages
http://dx.doi.org/10.1155/2014/430518
Research Article

Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial

1Clinical Research Dr. Tröger, Zechenweg 6, 79111 Freiburg, Germany
2Institute of Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia

Received 10 October 2013; Revised 24 December 2013; Accepted 13 January 2014; Published 20 February 2014

Academic Editor: Matthias Kröz

Copyright © 2014 Wilfried Tröger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. Ganz, L. Kwan, A. L. Stanton et al., “Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial,” Journal of the National Cancer Institute, vol. 96, no. 5, pp. 376–387, 2004. View at Google Scholar · View at Scopus
  2. B.-M. Heiny, “Additive therapie mit standardisiertem Mistelextrakt reduziert die Leukopenie und verbessert die Lebensqualität von Patientinnen mit fortgeschrittenem Mammakarzinom unter palliativer Chemotherapie (VEC-Schema),” Krebsmedizin, vol. 12, pp. 1–14, 1991. View at Google Scholar
  3. B. K. Piao, Y. X. Wang, G. R. Xie et al., “Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial,” Anticancer Research, vol. 24, no. 1, pp. 303–309, 2004. View at Google Scholar · View at Scopus
  4. V. F. Semiglasov, V. V. Stepula, A. Dudov, W. Lehmacher, and U. Mengs, “The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial,” Anticancer Research, vol. 24, no. 2, pp. 1293–1302, 2004. View at Google Scholar · View at Scopus
  5. V. F. Semiglazov, V. V. Stepula, A. Dudov, J. Schnitker, and U. Mengs, “Quality of life is improved in breast cancer patients by standardised mistletoe extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial,” Anticancer Research, vol. 26, no. 2, pp. 1519–1529, 2006. View at Google Scholar · View at Scopus
  6. G. S. Kienle, A. Glockmann, M. Schink, and H. Kiene, “Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research,” Journal of Experimental and Clinical Cancer Research, vol. 28, no. 1, article 79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Beuth, B. Schneider, and J. M. Schierholz, “Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative Epidemiological Cohort Study,” Anticancer Research, vol. 28, no. 1, pp. 523–527, 2008. View at Google Scholar · View at Scopus
  8. P. R. Bock, W. E. Friedel, J. Hanisch, M. Karasmann, and B. Schneider, “Efficacy and safety of long-term complementary treatment with standardized european mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma / results of a multicenter, comparative, epidemiological cohort study in Germany and Switzerland,” Drug Research, vol. 54, no. 8, pp. 456–466, 2004. View at Google Scholar · View at Scopus
  9. K. Schumacher, B. Schneider, G. Reich et al., “Influence of postoperative complementary treatment with lectin-standardized Mistletoe extract on breast cancer patients. a controlled epidemiological multicentric retrolective cohort study,” Anticancer Research, vol. 23, no. 6, pp. 5081–5087, 2003. View at Google Scholar · View at Scopus
  10. W. Tröger, S. Jezdić, Z. Ždrale, N. Tišma, H. J. Hamre, and M. Matijašević, “Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone,” Breast Cancer, vol. 3, no. 1, pp. 35–45, 2009. View at Google Scholar · View at Scopus
  11. L. Auerbach, V. Dostal, I. Václavik-Fleck et al., “Signifikant höherer Anteil aktivierter NK-Zellen durch additive Misteltherapie bei chemotherapierten Mamma-CA-Patientinnen in einer prospektiven randomisierten doppelblinden Studie,” in Fortschritte in der Misteltherapie. Aktueller Stand der Forschung Und Klinischen Anwendung, R. Scheer, R. Bauer, H. Becker, V. Fintelmann, F. H. Kemper, and H. Schilcher, Eds., pp. 543–554, KCV, Essen, Germany, 2005. View at Google Scholar
  12. I. Gerhard, “Problems of randomised treatment studies in complementary medicine. Forsch Komplementämed,” Klass Naturheilkd, vol. 7, pp. 34–35, 2000. View at Google Scholar
  13. M. Rostock and R. Huber, “Randomized and double-blind studies—demands and reality as demonstrated by two examples of mistletoe research,” Forschende Komplementarmedizin und Klassische Naturheilkunde, vol. 11, no. 1, pp. 18–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Ziegler, “Mistletoe preparation iscador: are there methodological concerns with respect to controlled clinical trials?” Evidence-Based Complementary and Alternative Medicine, vol. 6, no. 1, pp. 19–30, 2009. View at Publisher · View at Google Scholar
  15. N. K. Aaronson, S. Ahmedzai, B. Bergman et al., “The european organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology,” Journal of the National Cancer Institute, vol. 85, no. 5, pp. 365–376, 1993. View at Google Scholar · View at Scopus
  16. P. M. Fayers, N. K. Aaronson, K. Bjordal, M. Groenvold, D. Curran, and A. Bottomley, The EORTC QLQ-C30 Scoring Manual, EORTC Quality of Life Group, European Organization for Research and Treatment of Cancer, Brussels, Belgium, 3rd edition, 2001.
  17. E. Brunner and F. Langer, Nichtparametrische Analyse Longitudinaler Daten, Oldenbourg, München, Germany, 1999.
  18. D. Osoba, A. Bezjak, M. Brundage, B. Zee, D. Tu, and J. Pater, “Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of the National Cancer Institute of Canada Clinical Trials Group,” European Journal of Cancer, vol. 41, no. 2, pp. 280–287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Calvert, J. Blazeby, D. G. Altman, D. A. Revicki, D. Moher, and M. D. Brundage, “Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension,” The Journal of the American Medical Association, vol. 309, no. 8, pp. 814–822, 2013. View at Google Scholar
  20. J. Cohen, Statistical Power Analysis for the Behavioral Sciences, Routledge Academic, New York, NY, USA, 1988.
  21. A. Hróbjartsson and P. C. Gøtzsche, “Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment,” The New England Journal of Medicine, vol. 344, no. 21, pp. 1594–1602, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Hróbjartsson and P. C. Gøtzsche, “Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment,” Journal of Internal Medicine, vol. 256, no. 2, pp. 91–100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Hróbjartsson and P. C. Gøtzsche, “Placebo interventions for all clinical conditions,” Cochrane Database of Systematic Reviews, no. 3, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Horneber, G. Bueschel, R. Huber, K. Linde, and M. Rostock, “Mistletoe therapy in oncology,” Cochrane Database of Systematic Reviews, no. 2, p. CD003297, 2008. View at Google Scholar · View at Scopus
  25. G. S. Kienle and H. Kiene, “Influence of Viscum album L (European Mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies,” Integrative Cancer Therapies, vol. 9, no. 2, pp. 142–157, 2010. View at Publisher · View at Google Scholar · View at Scopus